홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
NUVB
#3996
Nuvation Bio Inc.
5.9
2
+5.71%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+5.71%
월간 변동
+5.53%
6달 변화
+98.66%
년간 변동율
+203.59%
이전 종가
5.6
0
Open
5.7
9
Bid
Ask
Low
5.7
9
High
5.9
2
양
1 640
마켓
주식
헬스케어
NUVB
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
335.25 M
337.68 M
336.84 M
336.84 M
336.84 M
—
Valuation ratios
Enterprise value
740.7 M
1.77 B
656.57 M
472.02 M
1.22 B
4.12 B
Price to earnings ratio
-1
-1.26
-0.77
-4.06
-7.55
-13.64
Price to sales ratio
0.29
0.09
0.05
0.04
0.04
0.22
Price to cash flow ratio
0.01
0.01
0
0
0.01
0.02
Price to book ratio
0
0
0
0
0
0
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.07
-0.09
-0.11
-0.09
-0.09
-0.38
Return on equity %
-0.08
-0.11
-0.13
-0.16
-0.17
-0.56
Return on invested capital %
-608.13
-683.06
-687.1
-642.14
-511.99
-2 524.3
Gross margin %
84.18
26.18
32.1
46.7
74.47
179.45
Operating margin %
-6 616.37
-944.53
-1 913.23
-1 315.73
-430.14
-4 603.62
EBITDA margin %
—
—
—
—
-428.51
—
Net margin %
-5 668.5
-865.79
-1 726.2
-1 220.92
-425.24
-4 238.15
Liquidity ratios
Quick ratio
—
—
9.01
9.38
8.39
—
Current ratio
9.57
9.04
9.01
9.39
8.48
35.92
Inventory turnover
—
—
149.57
9.1
1.07
—
Asset turnover
0
0.01
0.01
0.01
0.02
0.05
Solvency ratios
Debt to assets ratio
—
—
0.21
0.08
0.09
—
Debt to equity ratio
—
—
0.25
0.14
0.16
—
Long term debt to total assets ratio
—
—
0.2
0.07
0.08
—
Long term debt to total equity ratio
—
—
0.24
0.13
0.14
—
Per share metrics
Operating cash flow per share
-126.42
-172.27
-125.89
-141.83
-155.28
-595.27
EBIT per share
-195.62
-200.7
-174.25
-187.2
-165.69
-727.84
EBITDA per share
—
—
—
—
-165.07
—
Total debt per share
—
—
312.11
154.72
154.75
—
Cash per share
2 233.3
1 870.33
1 363.44
1 789.08
1 612.01
6 634.85
Net current asset value per share
2 297.76
1 958
1 404.46
1 834.66
1 695.64
6 892.76
Tangible book value per share
2 033.21
1 708.38
1 225.74
1 062.05
922.5
4 918.68
Working capital per share
2 057.67
1 741.29
1 248.61
1 639.32
1 495.61
6 124.83
Book value per share
2 044.51
1 725.58
1 238.76
1 097.8
956.8
5 018.94
뉴스
Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Tracking David Abrams' Abrams Capital Management Portfolio - Q4 2025 Update
Nuvation Bio expands SIGMA trial to phase 3 for IDH1-mutant glioma
누베이션 바이오, Ibtrozi 판매 호조에 B.Riley ’매수’ 유지
Nuvation Bio stock maintains Buy rating at B.Riley on Ibtrozi sales momentum
Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy (NYSE:NUVB)
누베이션 바이오, Truist Securities 목표 주가 13달러로 상향
Truist Securities raises Nuvation Bio stock price target to $13 on Ibtrozi uptake
Jones Trading raises Nuvation Bio stock price target to $12 on safusidenib study
Down 24% in 4 Weeks, Here's Why Nuvation Bio (NUVB) Looks Ripe for a Turnaround
누베이션 바이오 목표 주가 17달러로 하향 조정
Nuvation Bio stock price target lowered to $17 at H.C. Wainwright